Delcath Systems markets Hepzato Kit for the treatment of uveal melanoma with unresectable hepatic metastases. Click here to read my analysis of DCTH stock.

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

Turnstone, which went public via an $80 million IPO in 2023, ended September 2024 with $45.3 million to hand, which the ...

Pfizer only picked up an accelerated approval from the FDA for its Braftovi-based combination regimen for colorectal cancer ...

On World Cancer Day 2025, learn about 10 warning signs of cancer you shouldn’t ignore, from unexplained weight loss to ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, on World Cancer Day, we come together to raise awareness, promote early detection and encourage prevention.

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Foghorn Therapeutics Inc.’s FHTX share price has surged by 15.29%, which has investors questioning if this is right time to ...

Nearly 50% of cancer cases can be prevented through simple lifestyle changes. Preventing cancer doesn’t require extreme measures—just simple, consiste ...

World Cancer Day is a global initiative dedicated to raising awareness about cancer prevention, detection, and treatment.